BCL6 and T-cell non-Hodgkin lymphoma: Our data showed that the K607E mutation in BCOR—which results in the protein being unable to bind to BCL6— significantly enhanced cell proliferation, AKT phosphorylation, and IL-2 production in T cell lymphoma lines (Fig. 2).